Actively Recruiting

Age: 18Years +
All Genders
ID04529798

A Monocentric Clinical Study Evaluating Clinical and Patient-reported Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless

Led by Arthro Medics AG · Updated on 2024-07-31

60

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the clinical, radiographical, and patient-reported outcomes of SMR Stemless Reverse Shoulder Arthroplasty used as a standard treatment for conditions like rotator cuff tear arthropathy and osteoarthritis of the shoulders. The study includes both retrospective and prospective groups and aims to assess the incidence of any complications over at least two years of follow-up. The study follows patients at standard care time points: baseline, 6 weeks, 6 months, 12 months, and 24 months after surgery. These visits are used to monitor the shoulder arthroplasty outcomes without additional interventions beyond usual care. Both clinical evaluations and imaging are used to track implant stability and related measures. Participants will undergo assessments including the Subjective Shoulder Value score and other shoulder function scores up to 5 years after surgery. Radiographic evaluations for implant loosening and stability are performed at 1 year. Patient-reported pain and function questionnaires are collected during follow-up. The study involves monitoring for complications and collecting data on patient experiences over time.

CONDITIONS

Brief Title

Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of rotator-cuff arthropathy or osteoarthritis
  • Ability and willingness to provide written informed consent
Not Eligible

You will not qualify if you...

  • Female patients who are pregnant, nursing, or planning a pregnancy
  • Any adult patient with contraindications to SMR Stemless Reverse Shoulder Arthroplasty as stated in the current local instructions for use
  • Patients who do not consent to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Surveillance

Duration - 24 months

Participants who have undergone SMR Stemless Reverse Shoulder Arthroplasty are observed to evaluate clinical, patient-reported, and radiographical outcomes.

Baseline and postoperative visits at 6 weeks, 6 months, 12 months, and 24 months

Trial Site Locations

Total: 1 location

1

Arthro Medics AG

Basel, Canton of Basel-City, Switzerland, 4054

Actively Recruiting

Loading map...

Research Team

C

Claudio Rosso, PD Dr. med

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Adipose-Derived Biocellular Regenerative Therapy in Treatmen...

Osteoarthritis

Actively Recruiting

2 locations

Arthroscopic Rotator Cuff Repair with Bioinductive Implant f...

Rotator Cuff Tears

Actively Recruiting

1 location

Clinical and Radiological Outcomes of Medacta Shoulder Syste...

Primary Osteoarthritis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here